Integrated analysis of the role of PR/SET domain 14 in gastric cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.PRDM14 promotes gastric cancer progression by regulating cell growth, migration, and epigenetic mechanisms. Targeting PRDM14 may offer a new therapeutic strategy for gastric cancer patients.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Genetics
Background
- Gastric cancer is a prevalent malignancy with limited treatment options for advanced stages.
- PRDM14 is implicated in other cancers but its role in gastric cancer remains unclear.
Purpose Of The Study
- To investigate the expression and function of PRDM14 in gastric cancer.
- To evaluate PRDM14 as a prognostic marker and potential therapeutic target.
Main Methods
- Pan-cancer analysis of PRDM14 expression.
- Quantitative PCR, Western blotting, and immunohistochemistry.
- PRDM14 gene silencing and functional assays.
- Prognostic model development and validation.
- Drug sensitivity prediction using public databases.
Main Results
- PRDM14 is significantly overexpressed in gastric cancer cell lines and patient tissues.
- PRDM14 silencing inhibits cell proliferation, induces apoptosis, and arrests cell cycle.
- PRDM14 influences epigenetic regulation by modulating DNA methyltransferases and transcription factors.
- A validated PRDM14-based prognostic model predicts patient survival.
- PRDM14 expression correlates with sensitivity to specific small-molecule drugs.
Conclusions
- PRDM14 acts as a positive regulator of gastric cancer progression.
- PRDM14 represents a potential therapeutic target for gastric cancer treatment.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
